Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Dr. Sulaiman Al Habib Medical Services Group / 2025 Annual Results

Dr. Sulaiman Al Habib Medical Services Group 2025 Annual Results

Revenue
SAR 13.71B
Net Profit
SAR 2.40B
EPS
SAR 6.86
Operating Cash Flow
SAR 3.40B

Dr. Sulaiman Al Habib Medical Services Group (4013) reported full year 2025 revenue of SAR 13.71B, up 22.4% from SAR 11.20B in 2024. Net profit came in at SAR 2.40B, up 3.7% year on year. Earnings per share were SAR 6.86. The company generated SAR 3.40B in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.42 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.42.

Key Financial Metrics

Metric20252024
RevenueSAR 13.71BSAR 11.20B
Net ProfitSAR 2.40BSAR 2.32B
Net Margin17.5%20.7%
ROE30.4%32.3%
EPSSAR 6.86SAR 6.62
Total AssetsSAR 23.20BSAR 20.56B
Total EquitySAR 7.90BSAR 7.18B
Total LiabilitiesSAR 14.78BSAR 12.95B
Operating Cash FlowSAR 3.40BSAR 2.97B

Year on Year Comparison

Revenue increased by 22.4% compared to 2024. Net profit increased by 3.7%. Both revenue and profit grew — indicating expanding business.

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-02-16.